Skip to main content

PBPK modeling solutions as a potential risk mitigation strategy for pH dependent DDIs

Drug- Drug Interaction (DDI) is a crucial aspect in new drug development due potential impact on patients’ safety. Pharmacokinetic interactions at the level of absorption, distribution, metabolism and elimination should be considered in any clinical pharmacology submission for regulatory approval.